Workshop on the development of an EMEA transparency policy

• Datums:
  Ceturtdiena, 22 Janvāris 2009, Visu dienu
• Atrašanās vieta:
  European Medicines Agency, Amsterdam, the Netherlands

Discussion with invited stakeholders to express their initial thoughts and provide feedback on their understanding and expectations on the level of transparency of EMEA activities.

Documents

Agenda - Workshop on the EMEA transparency policy

Reference Number: EMEA/665540/2008

Workshop on the EMEA transparency policy - List of participants

Reference Number: EMEA/665471/2008

Report on workshop on the development of an EMEA transparency policy

Reference Number: EMEA/665540/2008

Overview current EMEA transparency measures

Workshop on the development of an EMEA transparency policy

Discussion on the EMEA transparency policy - Perspectives from Healthcare Professionals

Pharmaceutical Industry views

IFAH-Europe views

Workshop on the development of an EMEA transparency policy - Draft key principles

Commercial confidential information - Principles to be considered

Transparency at the MEB: a necessity

Key messages in relation to the importance of commercially confidential information

Presentation given by The Association of the European Self-Medication Industry (AESGP)

Transparency and commercially confidential information - EGA’s perspective